DIAMOX IV 500MG DIN 02238074
Status: Cancelled Post Market
Holder: WYETH-AYERST CANADA INC.
Molecule: ACETAZOLAMIDE (ACETAZOLAMIDE SODIUM)
Health Canada record
| Active ingredient(s) | ACETAZOLAMIDE (ACETAZOLAMIDE SODIUM) 500 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01EC01 ACETAZOLAMIDE |
| Original market date | 02-Dec-1998 |
| Current status date | 07-May-2001 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ACETAZOLAMIDE (ACETAZOLAMIDE SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02537893 | ACETAZOLAMIDE FOR INJECTION USP | MARCAN PHARMACEUTICALS INC | Powder For Solution | ACETAZOLAMIDE (ACETAZOLAMIDE SODIUM) 500 MG | Marketed |
| 02358328 | ACETAZOLAMIDE FOR INJECTION, USP | STERIMAX INC | Powder For Solution | ACETAZOLAMIDE (ACETAZOLAMIDE SODIUM) 500 MG | Dormant |
| 02039249 | DIAMOX PWS 500MG/VIAL | STORZ, DIVISION OF WYETH-AYERST CANADA INC. | Powder For Solution | ACETAZOLAMIDE (ACETAZOLAMIDE SODIUM) 500 MG | Cancelled Post Market |